I was reading through the MyRACentral News Page the other day and an article about Celebrex caught my eye. Celebrex is a non-steroidal anti-inflammatory (NSAID) in the COX-2 inhibitor family. A similar drug, Vioxx, manufactured by rival company Merck, was withdrawn from the market in September 2004 because of increased risk of serious blood clotting, heart attacks and strokes. Three months later the FDA asked Pfizer to voluntarily stop all direct-to-consumer advertising of Celebrex. A few months later, Pfizer also pulled its drug, Bextra, from the market in early 2005, because of a link to a serious skin disorder. Although Pfizer has not advertised, Celebrex has remained on the market because the FDA determined that the benefits of the drug outweigh the significant risks. I haven’t seen the new media or print ads yet, but I think the new spin on the risks that is discussed in the news article is interesting. Apparently, Pfizer begins the...
Generic Name: CELECOXIB - ORAL Pronounced: (sell-eh-COX-ib) Celebrex Oral Interactions
Your doctor or pharmacist may already be aware of any
possible drug interactions and may be monitoring you for them. Do not start,
stop, or change the dosage of any medicine before checking with them
This drug should not be used with the following medication
because very serious interactions may occur:
If you are currently using the medication listed above,
tell your doctor or pharmacist before starting celecoxib.
Before using this medication, tell your doctor or
pharmacist of all prescription and nonprescription products you may use,
anti-platelet drugs (e.g., cilostazol,
high blood pressure drugs (including ACE inhibitors such as
captopril, lisinopril and angiotensin II receptor blockers such as losartan,
oral bisphosphonates (e.g., alendronate)
December 28, 1992, marked a new era for Migraine sufferers with FDA approval of injectable Imitrex (sumatriptan). Imitrex was the first Migraine abortive triptan medication, a class of medications that many Migraineurs would come to call “miracle drugs.” Imitrex tablets were approved by the FDA in 1995. Since then, six more triptans have entered the market – Maxalt , Zomig , Amerge , Axert , Frova , and Relpax . Although triptans are a marked improvement over previous treatment options, many Migraineurs have not been fully satisfied with their results. Some do not achieve full relief from triptans, and the recurrence of Migraines within 24 hours of the first dose has been common. With the patents on sumatriptan nearing their expiration, both generics of the current forms – injections, tablets, and nasal spray – and other medications containing sumatriptan are now in development and testing. The results involving Trexima, one such medication that is a com...
You should knowAnswers to your question are meant to provide general health information but should not replace medical advice you receive from a doctor. No answers should be viewed as a diagnosis or recommended treatment for a condition. Content posted by community members does not necessarily reflect the views of Remedy Health Media, which also reserves the right to remove material deemed inappropriate.